A new study reveals that lipid accumulation product (LAP), a novel indicator of central fat, may serve as an early warning marker for declining bone health.
Osteoporosis remains a major global health concern, especially for adults over 50, with more than 158 million affected worldwide. While obesity and bone health have long been intertwined, traditional obesity markers like BMI and waist circumference have shown limited predictive value for bone mineral density (BMD). A new approach—lipid accumulation product (LAP)—may hold the key to more accurate risk assessment.
Understanding Lipid Accumulation Product and Its Importance
LAP combines serum triglyceride levels and waist circumference into a single metric. It’s already associated with health risks like insulin resistance and metabolic syndrome. However, its connection with bone health, specifically lumbar spine BMD, has remained unexplored—until now.
Researchers analyzed data from 3,883 participants in the U.S. NHANES survey (2011–2018). The aim was to uncover a potential link between LAP and lumbar BMD using statistical modeling, including subgroup and interaction analysis.
Key Findings: LAP and BMD Show a Threshold Relationship
Results revealed a non-linear negative relationship between LAP and lumbar BMD. Notably, the association only became significant once LAP passed a critical threshold (ln-LAP ≈ 2.85). Below this threshold, no meaningful relationship was detected.
Even more compelling: this relationship remained consistent across age, gender, ethnicity, and health status, indicating that the LAP-BMD link is robust and generalizable.
Clinical Implications: LAP as an Osteoporosis Predictor
These findings offer promising implications for healthcare professionals. By incorporating LAP into routine screening, clinicians might be able to identify early signs of bone loss before clinical symptoms appear. This could lead to earlier interventions, slowing or even preventing the progression to osteoporosis.
However, as the study authors note, further longitudinal research is needed to determine causality and extend findings to other bone sites such as the femur.
Conclusion: Monitoring LAP for Better Bone Health
This groundbreaking study supports the clinical utility of LAP as a bioindicator for osteoporosis risk, particularly in younger adults. As we confront rising rates of both obesity and osteoporosis, such predictive tools could be transformative in shaping future prevention strategies.
By integrating LAP measurement into preventive health checkups, clinicians could unlock a proactive pathway to preserving skeletal strength—and reducing long-term fracture risk.
For more information: Cui, A., Zhuang, Y., Wei, X. et al. The association between lipid accumulation products and bone mineral density in U.S. Adults, a nationally representative cross-sectional study. Sci Rep 15, 16373 (2025), DOI: 10.1038/s41598-025-00833-6, https://www.nature.com/articles/s41598-025-00833-6
more recommended stories
Higher BMI and Hypothyroidism Risk StudyA major longitudinal study from Canada.
Therapeutic Plasma Exchange Reduces Biological AgeTherapeutic plasma exchange (TPE), especially when.
Childhood Cancer Diagnosis Delays PersistDelays in childhood cancer diagnosis remain.
Hypothalamic Changes in Eating Disorders ExplainedGroundbreaking MRI scans reveal microstructural hypothalamic.
Rapid Blood Test for Rare Diseases Revolutionizes Pediatric DiagnosisA groundbreaking blood test developed by.
Blood Markers for Teen Depression: A Breakthrough in Early DetectionMental health professionals and researchers have.
Long-Term Antidepressant Use Increases Withdrawal RiskA new study led by researchers.
Cell Painting Identifies Flavonoids for Bladder CancerIn a breakthrough led by Baylor.
Young Adult Cancer Survivors Mental Health StrugglesNew research from the University of.
Lecanemab Access Disparities Limit EquityLecanemab access disparities are raising red.
Leave a Comment